Health IT Analytics August 27, 2020
Jessica Kent

The findings could help explain why some individuals with high genetic disease risk don’t go on to develop genetic conditions.

In people with a single-gene variant that contributes to high genetic disease risk – specifically for heart disease, breast cancer, or colorectal cancer – the rest of the genome can alter that risk, according to a study published in Nature Communications.

Some individuals are genetically predisposed to disease, but these disease predictions aren’t always accurate as not everyone carrying these high-risk single-gene variants develops the disease.

A team from the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), Harvard Medical School collaborated with IBM Research and Color to determine why this occurs. The group focused on three...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Survey / Study, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article